Revenue | ₹4.84Cr |
Net Profits | ₹0.02Cr |
Net Profit Margins | 0.41% |
Beryl Drugs Ltd’s revenue fell -23.05% since last year same period to ₹4.84Cr in the Q1 2025-2026. On a quarterly growth basis, Beryl Drugs Ltd has generated -7.28% fall in its revenue since last 3-months.
Beryl Drugs Ltd’s net profit fell -94.59% since last year same period to ₹0.02Cr in the Q1 2025-2026. On a quarterly growth basis, Beryl Drugs Ltd has generated -86.67% fall in its net profits since last 3-months.
Beryl Drugs Ltd’s net profit margin fell -92.98% since last year same period to 0.41% in the Q1 2025-2026. On a quarterly growth basis, Beryl Drugs Ltd has generated -85.62% fall in its net profit margins since last 3-months.
The revenue for Beryl Drugs Ltd in the Q1 results 2025 was ₹4.84Cr.
The net profit for Beryl Drugs Ltd in the Q1 results 2025 was ₹0.02Cr.
The net profit margin for Beryl Drugs Ltd in the Q1 results 2025 was 0.41%.
The revenue for Beryl Drugs Ltd in the Q1 results 2024 was ₹6.29Cr.
The net profit for Beryl Drugs Ltd in the Q1 results 2024 was ₹0.37Cr.
The net profit margin for Beryl Drugs Ltd in the Q1 results 2024 was 5.88%.